Epinephrine autoinjectors, otherwise known as EpiPens, are medical devices used to inject a measured dose of epinephrine to help treat anaphylaxis. Many people depend on these devices to survive potentially life-threatening allergic responses. Just last month, Meridian Medical Technologies, a manufacturer of Mylan’s EpiPen, expanded a recent voluntary recall to include medical devices shipped to the United States.
The original recall was issued on March 20th and affected about 80,000 of the devices shipped to locations outside of the country. However, Mylan NV announced the addition recalled items were part of 13 lots of EpiPen and EpiPen Jr. 2-Pak Auto-Injectors that carry expiration dates between April and October.
The recalls were the result of 2 reported failures in the products that occurred outside the United States because of a potential defect in a supplier component. The error could potentially make the device hard to activate in an emergency, which could cause significant health consequences for a patient in a life-threatening situation.
While there have been no device failures reported in the United States, the voluntary recall is also being initiated in the markets of Europe, North and South America, and Asia. Additionally, the recalled items will be replaced at no cost.
For more information about the recall, customers should contact Mylan at (800) 796-9526 or email Mylan customer service at email@example.com.
If you or your loved one has been injured by a faulty medical product, contact our skilled San Francisco defective pharmaceuticals attorneys. Kaiser Gornick LLP is dedicated to helping the victims of medical device failures seek compensation for their injuries. Manufacturers should not put their profits above the health and wellness of the people they help. Let us see how we can help your case.
Contact us at or fill out our online form to schedule a free initial case review today.